-
Something wrong with this record ?
A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas
A. Guha, Z. Musil, A. Vicha, T. Zelinka, K. Pacak, J. Astl, M. Chovanec
Language English Country Slovakia
Document type Journal Article
Links
PubMed
31307198
DOI
10.4149/neo_2018_181208n933
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Mutation MeSH
- Head and Neck Neoplasms * genetics MeSH
- Paraganglioma * genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Head and neck paragangliomas Paragangliomas and pheochromocytomas are rare, mostly benign neuroendocrine tumors, which are embryologically derived from neural crest cells of the autonomic nervous system. Paragangliomas are essentially the extra-adrenal counterparts of pheochromocytomas. As such this family of tumors can be subdivided into head and neck paragangliomas, pheochromocytomas and thoracic and abdominal extra-adrenal paragangliomas. Ten out of fifteen genes that contribute to the development of paragangliomas are more susceptible to the development of head and neck paragangliomas when mutated. Gene expression profiling revealed that pheochromocytomas and paragangliomas can be classified into two main clusters (C1 and C2) based on transcriptomes. These groups were defined according to their mutational status and as such strongly associated with specific tumorigenic pathways. The influence of the main genetic drivers on the somatic molecular phenotype was shown by DNA methylation and miRNA profiling. Certain subunits of succinate dehydrogenase (SDHx), von Hippel-Lindau (VHL) and transmembrane protein 127 (TMEM127) still have the highest impact on development of head and neck paragangliomas. The link between RAS proteins and the formation of pheochromocytoma and paragangliomas is clear due to the effect of receptor tyrosine-protein kinase (RET) and neurofibromatosis type 1 (NF1) in RAS signaling and recent discovery of the role of HRAS. The functions of MYC-associated factor X (MAX) and prolyl hydroxylase 2 (PHD2) mutations in the contribution to the pathogenesis of paragangliomas still remain unclear. Ongoing studies give us insight into the incidence of germline and somatic mutations, thus offering guidelines to early detection. Furthermore, these also show the risk of mistakenly assuming sporadic cases in the absence of definitive family history in head and neck paragangliomas.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19034451
- 003
- CZ-PrNML
- 005
- 20191017153038.0
- 007
- ta
- 008
- 191007s2019 xo f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4149/neo_2018_181208N933 $2 doi
- 035 __
- $a (PubMed)31307198
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Guha, Anasuya $7 xx0229078 $u Department of Otorhinolaryngology, 3rd Faculty of Medicine and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic
- 245 12
- $a A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas / $c A. Guha, Z. Musil, A. Vicha, T. Zelinka, K. Pacak, J. Astl, M. Chovanec
- 520 9_
- $a Head and neck paragangliomas Paragangliomas and pheochromocytomas are rare, mostly benign neuroendocrine tumors, which are embryologically derived from neural crest cells of the autonomic nervous system. Paragangliomas are essentially the extra-adrenal counterparts of pheochromocytomas. As such this family of tumors can be subdivided into head and neck paragangliomas, pheochromocytomas and thoracic and abdominal extra-adrenal paragangliomas. Ten out of fifteen genes that contribute to the development of paragangliomas are more susceptible to the development of head and neck paragangliomas when mutated. Gene expression profiling revealed that pheochromocytomas and paragangliomas can be classified into two main clusters (C1 and C2) based on transcriptomes. These groups were defined according to their mutational status and as such strongly associated with specific tumorigenic pathways. The influence of the main genetic drivers on the somatic molecular phenotype was shown by DNA methylation and miRNA profiling. Certain subunits of succinate dehydrogenase (SDHx), von Hippel-Lindau (VHL) and transmembrane protein 127 (TMEM127) still have the highest impact on development of head and neck paragangliomas. The link between RAS proteins and the formation of pheochromocytoma and paragangliomas is clear due to the effect of receptor tyrosine-protein kinase (RET) and neurofibromatosis type 1 (NF1) in RAS signaling and recent discovery of the role of HRAS. The functions of MYC-associated factor X (MAX) and prolyl hydroxylase 2 (PHD2) mutations in the contribution to the pathogenesis of paragangliomas still remain unclear. Ongoing studies give us insight into the incidence of germline and somatic mutations, thus offering guidelines to early detection. Furthermore, these also show the risk of mistakenly assuming sporadic cases in the absence of definitive family history in head and neck paragangliomas.
- 650 12
- $a nádory hlavy a krku $x genetika $7 D006258
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 12
- $a paragangliom $x genetika $7 D010235
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Musil, Zdeněk $7 xx0107856 $u Department of Biology and Medical Genetics, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Vícha, Aleš, $d 1971- $7 xx0116880 $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Zelinka, Tomáš $7 xx0074465 $u Department of Endocrinology and Metabolism, 1st Faculty of Medicine and and General University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Pacák, Karel, $d 1958- $7 jo20000074102 $u Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States
- 700 1_
- $a Astl, Jaromír, $d 1964- $7 jn20020716588 $u Department of Ear, Nose and Throat and Maxillofacial Surgery, 3rd Faculty of Medicine and Military University Hospital, Charles University, Prague, Czech Republic
- 700 1_
- $a Chovanec, Martin, $d 1978- $7 xx0070641 $u Department of Otorhinolaryngology, 3rd Faculty of Medicine and Kralovske Vinohrady University Hospital, Charles University, Prague, Czech Republic
- 773 0_
- $w MED00003470 $t Neoplasma $x 0028-2685 $g Roč. 66, č. 5 (2019), s. 671-680
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31307198 $y Pubmed
- 910 __
- $a ABA008 $b A 1194 $c 659 $y p $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191017153506 $b ABA008
- 999 __
- $a ok $b bmc $g 1451111 $s 1073001
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 66 $c 5 $d 671-680 $e 20190629 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- LZP __
- $b NLK118 $a Pubmed-20191007